Nifty

:

25069.20

Sensex

:

81785.74

-44.80 (-0.18%)
-118.96 (-0.15%)

Login

Nifty
Sensex

:
:

25069.20
81785.74

-44.80 (-0.18%)
-118.96 (-0.15%)

Bafna Pharmaceuticals Ltd.

Pharmaceuticals & Drugs

Rating :

59/99

BSE: 532989 | NSE: BAFNAPH

Watchlist

NSE BSE

122.96

15-Sep-2025

Open
High
Low
Previous Close

122.7
122.96
119
117.11

Volume
Traded Value (lacs)
52 Week High
52 Week Low

21018
2583534.2
122.96
69

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

293.34
35.49
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

318.10
N/A
3.33

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

5.51
15.42
8.14

EBITDA CAGR (%)

10 Years
5 Years
3 Years

14.46
1.10
-7.10

PAT CAGR (%)

10 Years
5 Years
3 Years

-
-6.57
-28.47

P:E (Median)

8 Years
5 Years
3 Years

28.42
43.38
42.45

P:BV (Average)

8 Years
5 Years
3 Years

3.52
3.69
2.74

EV:EBITDA (Average)

8 Years
5 Years
3 Years

9.73
20.66
17.19

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated

Description Jun 25 Jun 24 Var% Mar 25 Mar 24 Var% Dec 24 Dec 23 Var% Sep 24 Sep 23 Var%
Net Sales 34.62 33.29 4.00% 39.06 41.40 -5.65% 33.19 28.44 16.70% 40.32 40.68 -0.88%
Expenses 29.55 32.08 -7.89% 35.95 38.51 -6.65% 30.13 30.52 -1.28% 36.53 36.67 -0.38%
EBITDA 5.07 1.21 319.01% 3.11 2.89 7.61% 3.06 -2.08 - 3.79 4.00 -5.25%
EBIDTM 14.64% 3.64% 7.97% 6.98% 9.22% -7.30% 9.40% 9.84%
Other Income 0.60 0.51 17.65% 1.02 0.52 96.15% 0.19 0.98 -80.61% 1.02 0.16 537.50%
Interest 0.91 0.65 40.00% 0.82 0.68 20.59% 0.64 0.58 10.34% 0.62 0.44 40.91%
Depreciation 1.37 1.44 -4.86% 0.22 1.27 -82.68% 1.66 1.27 30.71% 1.57 1.24 26.61%
PBT 3.39 -0.72 - 1.31 1.46 -10.27% 0.95 -2.94 - 2.62 2.48 5.65%
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT 3.39 -0.72 - 1.31 1.46 -10.27% 0.95 -2.94 - 2.62 2.48 5.65%
PATM 9.79% -2.17% 3.36% 3.52% 2.86% -10.35% 6.49% 6.11%
EPS 1.43 -0.31 - 0.55 0.61 -9.84% 0.40 -1.24 - 1.10 1.05 4.76%

Description Mar 25 Mar 24 Var% Dec 24 Dec 23 Var% Sep 24 Sep 23 Var% Jun 24 Jun 23 Var%
Net Sales 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Expenses 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBITDA 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBIDTM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Interest 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Depreciation 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PBT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PATM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Net Sales 147.19 145.86 152.47 115.35 85.14 71.22 42.47 43.63 47.17 64.96 85.32 Net Sales Growth 2.35% -4.34% 32.18% 35.48% 19.55% 67.69% -2.66% -7.50% -27.39% -23.86% Cost Of Goods Sold 78.42 80.94 86.73 63.07 39.93 31.75 16.17 23.94 33.34 49.52 61.59 Gross Profit 68.77 64.92 65.74 52.28 45.21 39.47 26.30 19.69 13.83 15.45 23.72 GP Margin 46.72% 44.51% 43.12% 45.32% 53.10% 55.42% 61.93% 45.13% 29.32% 23.78% 27.80% Total Expenditure 132.16 134.98 141.35 99.63 73.24 60.92 41.24 56.69 82.26 70.18 82.50 Power & Fuel Cost - 7.72 6.73 5.31 3.93 2.95 2.69 2.50 2.12 2.01 2.38 % Of Sales - 5.29% 4.41% 4.60% 4.62% 4.14% 6.33% 5.73% 4.49% 3.09% 2.79% Employee Cost - 21.03 19.03 15.87 14.65 11.98 10.25 9.01 7.47 6.62 6.41 % Of Sales - 14.42% 12.48% 13.76% 17.21% 16.82% 24.13% 20.65% 15.84% 10.19% 7.51% Manufacturing Exp. - 15.69 13.54 8.78 8.69 10.65 8.55 8.16 8.36 5.78 8.09 % Of Sales - 10.76% 8.88% 7.61% 10.21% 14.95% 20.13% 18.70% 17.72% 8.90% 9.48% General & Admin Exp. - 5.34 11.47 3.18 3.10 2.86 3.05 2.50 2.02 2.12 2.20 % Of Sales - 3.66% 7.52% 2.76% 3.64% 4.02% 7.18% 5.73% 4.28% 3.26% 2.58% Selling & Distn. Exp. - 3.17 2.80 2.11 2.87 0.65 0.40 0.81 2.15 1.23 0.44 % Of Sales - 2.17% 1.84% 1.83% 3.37% 0.91% 0.94% 1.86% 4.56% 1.89% 0.52% Miscellaneous Exp. - 1.10 1.06 1.33 0.06 0.07 0.12 9.77 26.80 2.89 0.44 % Of Sales - 0.75% 0.70% 1.15% 0.07% 0.10% 0.28% 22.39% 56.82% 4.45% 1.63% EBITDA 15.03 10.88 11.12 15.72 11.90 10.30 1.23 -13.06 -35.09 -5.22 2.82 EBITDA Margin 10.21% 7.46% 7.29% 13.63% 13.98% 14.46% 2.90% -29.93% -74.39% -8.04% 3.31% Other Income 2.83 3.04 3.52 3.27 1.76 0.75 0.26 0.39 31.26 1.14 1.24 Interest 2.99 2.73 2.29 2.04 0.79 0.74 0.10 2.13 6.81 11.34 12.47 Depreciation 4.82 4.89 5.00 5.33 5.49 4.48 3.27 3.42 3.65 3.89 4.11 PBT 8.27 6.30 7.35 11.62 7.37 5.83 -1.88 -18.23 -14.28 -19.31 -12.53 Tax 0.00 0.00 0.00 0.28 0.00 0.00 0.00 1.50 2.18 -0.84 -0.34 Tax Rate 0.00% 0.00% 0.00% 2.41% 0.00% 0.00% 0.00% -8.23% -15.27% 4.35% 2.71% PAT 8.27 4.15 7.35 11.34 5.22 5.83 -1.88 -19.73 -16.45 -18.47 -12.18 PAT before Minority Interest 8.27 4.15 7.35 11.34 5.22 5.83 -1.88 -19.73 -16.45 -18.47 -12.18 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 5.62% 2.85% 4.82% 9.83% 6.13% 8.19% -4.43% -45.22% -34.87% -28.43% -14.28% PAT Growth 2,853.57% -43.54% -35.19% 117.24% -10.46% - - - - - EPS 3.49 1.75 3.10 4.78 2.20 2.46 -0.79 -8.32 -6.94 -7.79 -5.14

Description TTM Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12
Net Sales - 42.47 43.63 47.17 64.96 85.32 138.79 185.34 175.77 128.63 Net Sales Growth - -2.66% -7.50% -27.39% -23.86% -38.53% -25.12% 5.44% 36.65% Cost Of Goods Sold - 16.17 23.94 33.34 49.52 63.00 77.80 124.51 122.43 85.98 Gross Profit - 26.30 19.69 13.83 15.45 22.32 60.99 60.83 53.34 42.65 GP Margin - 61.93% 45.13% 29.32% 23.78% 26.16% 43.94% 32.82% 30.35% 33.16% Total Expenditure - 41.25 56.70 82.30 70.77 84.80 115.33 162.50 153.29 109.99 Power & Fuel Cost - 2.69 2.50 2.13 2.05 2.54 2.01 2.08 2.03 1.73 % Of Sales - 6.33% 5.73% 4.52% 3.16% 2.98% 1.45% 1.12% 1.15% 1.34% Employee Cost - 10.25 9.01 7.47 6.81 6.94 10.74 13.98 10.88 5.83 % Of Sales - 24.13% 20.65% 15.84% 10.48% 8.13% 7.74% 7.54% 6.19% 4.53% Manufacturing Exp. - 8.09 8.08 8.36 6.06 8.19 13.02 11.08 9.73 11.43 % Of Sales - 19.05% 18.52% 17.72% 9.33% 9.60% 9.38% 5.98% 5.54% 8.89% General & Admin Exp. - 3.52 2.60 2.03 2.21 2.30 4.68 5.58 5.53 3.38 % Of Sales - 8.29% 5.96% 4.30% 3.40% 2.70% 3.37% 3.01% 3.15% 2.63% Selling & Distn. Exp. - 0.40 0.81 2.15 1.23 0.44 3.38 2.98 2.36 1.12 % Of Sales - 0.94% 1.86% 4.56% 1.89% 0.52% 2.44% 1.61% 1.34% 0.87% Miscellaneous Exp. - 0.12 9.77 26.82 2.90 1.39 3.70 2.29 0.33 0.51 % Of Sales - 0.28% 22.39% 56.86% 4.46% 1.63% 2.67% 1.24% 0.19% 0.40% EBITDA - 1.22 -13.07 -35.13 -5.81 0.52 23.46 22.84 22.48 18.64 EBITDA Margin - 2.87% -29.96% -74.48% -8.94% 0.61% 16.90% 12.32% 12.79% 14.49% Other Income - 0.26 0.39 31.33 1.14 1.98 4.90 1.85 3.04 1.48 Interest - 0.10 2.13 6.94 11.47 12.96 13.46 13.21 11.91 8.32 Depreciation - 3.27 3.48 3.97 4.22 4.86 5.99 8.99 8.25 6.30 PBT - -1.88 -18.29 -14.72 -20.36 -15.32 8.90 2.49 5.36 5.50 Tax - 0.00 1.07 2.19 -0.90 -0.18 -0.15 1.05 1.48 3.47 Tax Rate - 0.00% -5.85% -14.88% 4.42% 1.17% -2.47% 42.17% 26.96% 64.62% PAT - -2.17 -19.88 -16.74 -19.09 -14.03 6.18 1.40 3.96 1.85 PAT before Minority Interest - -1.88 -19.36 -16.91 -19.46 -15.14 6.22 1.44 4.01 1.91 Minority Interest - -0.29 -0.52 0.17 0.37 1.11 -0.04 -0.04 -0.05 -0.06 PAT Margin - -5.11% -45.56% -35.49% -29.39% -16.44% 4.45% 0.76% 2.25% 1.44% PAT Growth - - - - - - 341.43% -64.65% 114.05% EPS - -0.92 -8.39 -7.06 -8.05 -5.92 2.61 0.59 1.67 0.78

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Shareholder's Funds 84.81 80.84 73.45 61.96 56.77 50.95 20.79 40.52 44.97 59.44 Share Capital 23.66 23.66 23.66 23.66 23.66 2.37 23.66 23.66 18.66 18.66 Total Reserves 61.15 57.18 49.80 38.31 33.11 -6.78 -2.86 16.87 22.32 40.79 Non-Current Liabilities 16.42 12.76 9.65 6.17 5.39 3.02 29.20 27.96 41.54 38.54 Secured Loans 12.53 9.25 6.93 3.30 2.50 0.00 20.86 21.08 36.77 35.17 Unsecured Loans 1.50 1.50 1.51 2.02 0.00 3.02 2.13 2.17 2.24 0.00 Long Term Provisions 0.48 0.39 0.00 0.00 0.10 0.00 0.00 0.00 0.00 0.00 Current Liabilities 51.85 54.08 46.48 22.01 24.31 17.10 70.65 59.03 80.64 86.95 Trade Payables 30.95 35.42 28.46 12.40 10.69 12.54 39.42 27.82 23.40 29.93 Other Current Liabilities 10.95 7.38 4.85 3.46 3.62 4.56 7.99 7.92 13.86 11.71 Short Term Borrowings 8.57 10.01 11.91 4.59 10.00 0.00 23.24 23.29 43.37 45.31 Short Term Provisions 1.38 1.26 1.25 1.56 0.00 0.00 0.00 0.00 0.00 0.00 Total Liabilities 153.08 147.68 129.58 90.14 86.47 71.07 120.64 127.51 167.15 184.93 Net Block 58.78 40.21 40.23 38.85 35.97 34.97 37.02 39.94 43.32 46.99 Gross Block 105.53 99.49 94.66 87.94 79.57 74.09 72.87 72.54 72.41 72.44 Accumulated Depreciation 46.75 59.28 54.43 49.09 43.60 39.12 35.85 32.60 29.09 25.44 Non Current Assets 66.90 53.91 42.27 39.26 36.80 35.18 72.40 79.23 90.31 65.32 Capital Work in Progress 7.31 12.27 1.50 0.00 0.83 0.21 0.00 0.00 0.00 0.00 Non Current Investment 0.00 0.00 0.00 0.00 0.00 0.00 1.43 1.43 18.33 18.33 Long Term Loans & Adv. 0.81 0.73 0.54 0.42 0.00 0.00 32.95 37.33 28.07 0.00 Other Non Current Assets 0.00 0.70 0.00 0.00 0.00 0.00 1.00 0.53 0.58 0.00 Current Assets 84.73 93.77 87.31 50.88 49.67 35.88 48.24 48.29 76.85 118.89 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 28.09 29.64 22.22 20.28 15.44 11.41 9.28 10.67 16.74 16.35 Sundry Debtors 40.17 45.39 41.15 14.78 9.56 6.03 24.83 24.28 53.70 67.89 Cash & Bank 3.43 1.40 7.81 0.17 1.80 8.48 2.70 2.70 2.66 2.70 Other Current Assets 13.03 0.57 0.37 0.27 22.86 9.96 11.43 10.63 3.75 31.96 Short Term Loans & Adv. 12.41 16.77 15.76 15.37 11.24 2.54 5.19 6.12 0.86 30.36 Net Current Assets 32.88 39.69 40.84 28.87 25.36 18.78 -22.41 -10.75 -3.79 31.95 Total Assets 151.63 147.68 129.58 90.14 86.47 71.06 120.64 127.52 167.16 184.93

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12
Shareholder's Funds 51.11 19.06 37.93 42.67 57.75 71.78 68.86 67.45 63.82 Share Capital 2.37 23.66 23.66 18.66 18.66 18.66 18.66 18.66 18.38 Total Reserves -6.61 -4.60 14.27 20.01 39.10 53.12 50.20 45.67 39.57 Non-Current Liabilities 3.02 29.80 41.31 54.72 39.91 16.03 30.65 32.27 32.55 Secured Loans 0.00 20.86 21.08 36.77 35.17 11.64 22.95 25.20 26.33 Unsecured Loans 3.02 2.13 2.17 2.24 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Liabilities 17.10 70.82 59.85 81.47 95.05 111.09 135.43 160.01 121.77 Trade Payables 12.54 39.56 28.61 23.90 37.70 42.25 41.82 78.70 58.35 Other Current Liabilities 4.56 8.02 7.95 14.19 10.04 11.83 8.33 4.12 4.31 Short Term Borrowings 0.00 23.24 23.29 43.37 45.31 57.01 85.27 74.99 59.11 Short Term Provisions 0.00 0.00 0.00 0.00 2.00 0.00 0.00 2.20 0.00 Total Liabilities 71.31 119.47 138.36 178.31 192.53 199.83 235.83 260.58 218.94 Net Block 35.00 37.05 44.90 48.61 52.61 54.56 69.28 72.99 76.24 Gross Block 74.13 72.91 79.77 79.65 79.67 77.36 92.25 90.50 88.37 Accumulated Depreciation 39.12 35.85 34.88 31.04 27.06 22.80 22.97 17.51 12.13 Non Current Assets 35.22 71.00 89.62 101.12 69.51 72.74 71.88 74.50 77.20 Capital Work in Progress 0.21 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Non Current Investment 0.00 0.00 0.00 16.90 16.90 16.90 0.00 0.00 0.00 Long Term Loans & Adv. 0.00 32.95 44.20 35.03 0.00 0.00 0.00 0.00 0.00 Other Non Current Assets 0.00 1.00 0.53 0.58 0.00 1.28 2.60 1.51 0.96 Current Assets 36.10 48.47 48.74 77.18 122.30 127.09 156.48 178.55 136.62 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 11.41 9.28 10.67 16.74 16.38 16.12 27.40 22.21 23.92 Sundry Debtors 6.03 24.83 24.28 53.78 67.96 88.69 97.51 91.63 83.84 Cash & Bank 8.48 2.71 2.95 2.66 2.71 2.77 2.81 21.07 2.46 Other Current Assets 10.17 6.24 4.51 2.96 35.25 19.51 28.75 43.65 26.39 Short Term Loans & Adv. 2.75 5.40 6.32 1.05 33.58 18.12 24.36 39.92 23.16 Net Current Assets 19.00 -22.35 -11.11 -4.29 27.26 16.00 21.05 18.54 14.85 Total Assets 71.32 119.47 138.36 178.30 192.53 199.83 235.83 260.58 218.94

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Cash From Operating Activity 22.14 9.48 4.95 9.73 -13.61 -34.27 -1.09 -7.10 19.76 -2.97 PBT 4.15 7.35 11.62 5.19 5.83 -1.88 -18.23 -14.28 -19.31 -12.53 Adjustment 10.08 7.59 7.88 5.50 3.82 -20.22 5.42 -19.91 15.04 15.34 Changes in Working Capital 7.55 -5.28 -14.42 -0.80 -23.25 -12.17 11.71 27.09 24.03 -5.79 Cash after chg. in Working capital 21.79 9.66 5.08 9.90 -13.61 -34.27 -1.09 -7.10 19.76 -2.97 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid 0.35 -0.17 -0.13 -0.17 0.00 0.00 0.00 0.00 0.00 0.00 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -21.16 -15.05 -7.49 -6.54 -5.35 32.77 3.53 37.79 -14.37 -1.09 Net Fixed Assets -1.08 -15.60 -8.22 -7.54 -6.10 -1.43 -0.33 -0.13 0.03 -2.30 Net Investments 0.00 0.00 0.00 0.00 0.00 1.43 0.00 16.90 0.00 0.00 Others -20.08 0.55 0.73 1.00 0.75 32.77 3.86 21.02 -14.40 1.21 Cash from Financing Activity 1.06 -0.85 10.18 -4.81 12.28 7.27 -2.44 -30.65 -5.43 4.31 Net Cash Inflow / Outflow 2.04 -6.41 7.64 -1.63 -6.68 5.78 0.00 0.05 -0.04 0.25 Opening Cash & Equivalents 1.40 7.81 0.17 1.80 8.48 2.70 2.70 2.66 2.70 2.45 Closing Cash & Equivalent 3.43 1.40 7.81 0.17 1.80 8.48 2.70 2.70 2.66 2.70

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12
Cash From Operating Activity -34.31 -1.79 -7.05 -0.95 0.91 10.66 1.61 36.63 29.25 PBT -1.88 -18.29 -14.72 -20.36 -15.32 6.21 2.49 5.49 5.37 Adjustment -19.45 5.45 -19.53 15.50 15.84 -26.56 20.35 17.13 10.17 Changes in Working Capital -12.97 11.06 27.20 3.91 0.39 33.27 -20.77 14.91 14.75 Cash after chg. in Working capital -34.31 -1.79 -7.05 -0.95 0.91 12.92 2.08 37.53 30.30 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid 0.00 0.00 0.00 0.00 0.00 -2.26 -0.47 -0.90 -1.05 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity 32.77 15.36 37.97 -5.42 -0.36 60.13 -6.71 -6.10 -38.01 Net Fixed Assets -1.43 -0.33 -0.13 0.03 -2.30 14.96 -1.75 -1.71 Net Investments 1.43 0.00 16.90 0.00 0.00 -16.90 0.00 0.00 Others 32.77 15.69 21.20 -5.45 1.94 62.07 -4.96 -4.39 Cash from Financing Activity 7.30 -13.81 -30.63 6.31 -0.61 -70.83 -13.16 -11.93 -0.69 Net Cash Inflow / Outflow 5.77 -0.24 0.29 -0.06 -0.06 -0.04 -18.26 18.61 -9.46 Opening Cash & Equivalents 2.71 2.95 2.66 2.71 2.77 2.81 21.07 2.46 11.93 Closing Cash & Equivalent 8.48 2.71 2.95 2.66 2.71 2.77 2.81 21.07 2.46

Financial Ratios

Consolidated /

Standalone

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Book Value (Rs.) 35.85 34.17 31.05 26.19 24.00 -18.64 8.79 17.13 21.96 31.48 ROA 2.76% 5.30% 10.32% 5.91% 7.40% -1.96% -15.90% -11.17% -10.49% -6.58% ROE 5.01% 9.52% 16.75% 8.79% 22.26% -22.93% -64.36% -40.37% -37.05% -18.69% ROCE 6.31% 9.56% 16.12% 8.42% 10.62% -2.95% -20.90% -6.97% -5.98% -0.04% Fixed Asset Turnover 1.42 1.57 1.26 1.02 0.93 0.58 0.60 0.65 0.92 1.21 Receivable days 107.07 103.59 88.49 52.17 39.96 132.64 205.45 301.71 334.62 319.48 Inventory Days 72.23 62.08 67.24 76.57 68.82 88.92 83.48 106.06 91.07 66.92 Payable days 149.66 134.43 118.26 105.56 133.55 218.45 257.59 171.45 135.75 139.41 Cash Conversion Cycle 29.64 31.24 37.47 23.18 -24.77 3.11 31.34 236.32 289.94 246.98 Total Debt/Equity 0.33 0.30 0.31 0.18 0.23 -0.68 2.22 1.15 2.01 1.37 Interest Cover 2.52 4.21 6.70 7.57 8.85 -18.66 -7.57 -1.10 -0.70 0.00

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12
Book Value (Rs.) -17.93 8.06 16.03 20.73 30.57 38.47 32.90 30.44 28.74 ROA -1.97% -15.02% -10.68% -10.50% -7.72% 2.86% 0.58% 1.67% 0.87% ROE -25.42% -67.95% -44.15% -40.67% -23.51% 9.34% 2.44% 7.32% 3.61% ROCE -2.99% -21.59% -7.42% -6.77% -1.70% 12.60% 9.53% 11.44% 9.50% Fixed Asset Turnover 0.58 0.57 0.59 0.83 1.10 1.65 2.03 1.98 1.47 Receivable days 132.64 205.45 301.99 335.02 330.94 243.24 186.13 180.59 235.82 Inventory Days 88.92 83.48 106.06 91.14 68.66 56.86 48.82 47.48 67.28 Payable days 221.37 261.27 174.69 155.02 168.02 144.11 132.87 159.58 181.47 Cash Conversion Cycle 0.18 27.66 233.36 271.14 231.58 155.98 102.08 68.49 121.63 Total Debt/Equity -0.71 2.43 1.23 2.13 1.41 0.96 1.76 1.76 1.62 Interest Cover -18.72 -7.60 -1.12 -0.77 -0.18 1.45 1.19 1.46 1.65

Top Investors:

m7 global fund pcc aerion

m7 global fund pcc cell dewcap fund

zeal global opportunities fund

monarch networth finserve private limited

investor education and protection fund (iepf)

Annual Reports:

News Update:

Bafna Pharma - Quarterly Results
12th Aug 2025, 16:52 PM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback